Mark Bernard, MD
Nuclear Medicine · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 14
- Since medical school
- 29 years
- Medical College of Wisconsin, 1997
Offices
14 locations · Saint Agnes Medical Foundation · Beverly Radiology Medical Group III · Kern Radiology Medical Group Inc · Fresno Imaging Center · Desert Advanced Imaging Medical Center
Looking this up.
Hospitals listed: Saint Agnes Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bernard’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A66845 · Current
Licensed to practise in California · since 1998 · expires 2028-08-31 · Medical College of Wisconsin.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Nuclear Medicine - Nuclear Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Saint Agnes Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.312, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.141, Oct 2024 – Sep 2025
See every measure and the patient survey for Saint Agnes Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.312 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.141 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.18 to 1.94) · 2,342 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 197.82 (152.64 to 243.01) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 300 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 295 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 768 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.8 · 969 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 304 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 4,305 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.06 to 0.42) · 11,641 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 12,213 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.76 (2.91 to 6.61) · 2,466 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.09 (0 to 2.49) · 864 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.61 (0.26 to 2.96) · 2,362 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.1 (5.39 to 14.81) · 900 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.4 (1.2 to 7.59) · 882 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.84 (0.41 to 3.27) · 541 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.67 (0.14 to 1.19) · 9,626 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 58 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.835 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.004 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 412 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.6 · 1,002 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 28.8 · 296 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.5 · 894 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.8 · 981 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 1,061 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.4 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 412 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.6 to 15.9) · 1,324 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 863 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 32% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$162,344
Medicare paid this office $162,344 for 2,033 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Nuclear medicine study of bone and/or joint whole body | 148 | $33,250 | $222 |
| Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries | 30 | $21,277 | $709 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 240 | $15,148 | $63 |
| Dxa bone density measurement of hip, pelvis, spine | 1,089 | $14,681 | $12 |
| Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 46 | $11,260 | $245 |
See all 26 services
| Nuclear medicine study of bone and/or joint whole body | 148 | $33,250 | $222 |
| Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries | 30 | $21,277 | $709 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 240 | $15,148 | $63 |
| Dxa bone density measurement of hip, pelvis, spine | 1,089 | $14,681 | $12 |
| Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 46 | $11,260 | $245 |
| Nuclear medicine study of stomach to assess emptying | 42 | $10,453 | $249 |
| Nuclear medicine study of bone taken at different times | 27 | $7,409 | $274 |
| Nuclear medicine study of parathyroid | 26 | $5,639 | $217 |
| Nuclear medicine study of thyroid and thyroid function | 26 | $4,850 | $187 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 239 | $4,220 | $18 |
| Nuclear medicine study of kidney, blood, flow, and function with drug administration | 26 | $3,832 | $147 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 233 | $2,729 | $12 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 30 | $2,431 | $55 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 184 | $2,224 | $12 |
| Radioactive drug therapy through a tube inserted in an artery | 16 | $1,729 | $91 |
| Nuclear medicine study of liver and bile duct system | 57 | $1,584 | $28 |
| Nuclear medicine study of lung circulation | 55 | $1,570 | $28 |
| Dxa bone density measurement of hip, pelvis, spine | 129 | $1,271 | $10 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 23 | $745 | $32 |
| Nuclear medicine study of parathyroid with spect and ct scan | 13 | $740 | $57 |
| Nuclear medicine study of bone and/or joint whole body | 23 | $721 | $30 |
| Nuclear medicine study of bone taken at different times | 17 | $683 | $40 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 11 | $580 | $39 |
| Calculation of radiation therapy dose | 15 | $475 | $28 |
| Dxa bone density measurement of forearm, finger, hand, or foot | 20 | $473 | $20 |
| Injection, furosemide, up to 20 mg | 25 | $18 | None |
Who their Medicare patients are
2,033 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 10% · Women 74% · Also on Medicaid 28% · Health risk score 1.31. At or below the middle of the specialty; the typical nuclear medicine clinician is at 1.94.
Conditions among them: High blood pressure 75% · Diabetes 38% · Coronary heart disease 35% · Chronic kidney disease 30% · Cancer 23% · Heart failure 20% · Depression 20% · Atrial fibrillation 16% · COPD 15% · Stroke 7% · Dementia 6%.
The office billed $494,162, Medicare allowed $204,284 and paid $162,344; for 3,073 services of 44 kinds; $18 of it was for drugs given in the office and $162,326 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 2,033 | 3,073 | 74 | 1.31 | $494,162 | $162,344 |
| 2023 | 2,072 | 3,155 | 74 | 1.39 | $550,971 | $178,197 |
| 2022 | 1,847 | 2,870 | 74 | 1.39 | $507,856 | $161,888 |
| 2021 | 1,480 | 2,101 | 73 | 1.42 | $220,368 | $61,498 |
| 2020 | 1,242 | 1,733 | 73 | 1.55 | $167,301 | $45,487 |
| 2019 | 1,512 | 2,211 | 73 | 1.71 | $217,431 | $56,178 |
| 2018 | 977 | 1,298 | 73 | 2.45 | $230,778 | $61,895 |
| 2017 | 1,086 | 1,500 | 73 | 2.54 | $279,076 | $86,512 |
| 2016 | 1,166 | 1,882 | 73 | 2.35 | $318,614 | $105,638 |
| 2015 | 888 | 10,908 | 73 | 2.45 | $1,223,248 | $262,593 |
| 2014 | 1,692 | 15,091 | 72 | 2.03 | $2,080,465 | $451,725 |
| 2013 | 1,706 | 2,786 | 72 | 2.08 | $1,966,166 | $395,061 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 27 services
| Nuclear medicine study of bone and/or joint whole body | 167 | $39,236 | $228 |
| Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries | 38 | $27,519 | $706 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 303 | $17,297 | $57 |
| Nuclear medicine study of stomach to assess emptying | 47 | $12,414 | $264 |
| Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 49 | $11,971 | $244 |
| Nuclear medicine study of bone taken at different times | 39 | $10,739 | $275 |
| Dxa bone density measurement of hip, pelvis, spine | 969 | $9,385 | $10 |
| Nuclear medicine study of parathyroid | 26 | $5,753 | $221 |
| Nuclear medicine study of kidney, blood, flow, and function with drug administration | 35 | $5,053 | $140 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 300 | $4,871 | $16 |
| Nuclear medicine study of thyroid and thyroid function | 21 | $3,806 | $181 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 338 | $3,687 | $11 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 217 | $2,633 | $12 |
| Nuclear medicine study of liver and bile duct system | 64 | $1,774 | $27 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 26 | $1,721 | $56 |
| Nuclear medicine study of bone and/or joint whole body | 48 | $1,515 | $31 |
| Nuclear medicine study of parathyroid with spect and ct scan | 23 | $1,387 | $60 |
| Nuclear medicine study of lung circulation | 48 | $1,323 | $27 |
| Nuclear medicine study of bone taken at different times | 20 | $902 | $38 |
| Dxa bone density measurement of hip, pelvis, spine | 83 | $806 | $10 |
| Nuclear medicine study of stomach to assess emptying | 27 | $704 | $23 |
| Nuclear medicine study of heart muscle at rest and with stress and spect | 16 | $591 | $37 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 16 | $525 | $33 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 12 | $488 | $38 |
| Nuclear medicine study to assess blood loss | 11 | $457 | $38 |
| Nuclear medicine study of kidney, blood, flow, and function with drug administration | 11 | $414 | $38 |
| Injection, furosemide, up to 20 mg | 34 | $29 | None |
2022: 31 services
| Nuclear medicine study of bone and/or joint whole body | 193 | $48,048 | $240 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 293 | $17,895 | $61 |
| Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries | 20 | $14,878 | $708 |
| Nuclear medicine study of bone taken at different times | 34 | $9,955 | $293 |
| Dxa bone density measurement of hip, pelvis, spine | 839 | $8,311 | $10 |
| Nuclear medicine study of stomach to assess emptying | 29 | $8,077 | $279 |
| Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 30 | $7,146 | $238 |
| Nuclear medicine study of parathyroid | 25 | $5,977 | $239 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 263 | $4,522 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 295 | $3,413 | $12 |
| Nuclear medicine study of liver and bile duct system | 12 | $3,241 | $270 |
| Nuclear medicine study of thyroid and thyroid function | 15 | $2,924 | $195 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 233 | $2,824 | $12 |
| Nuclear medicine study of kidney, blood, flow, and function with drug administration | 17 | $2,611 | $145 |
| Nuclear medicine study of lung circulation | 73 | $2,182 | $28 |
| Nuclear medicine study of bone and/or joint whole body | 67 | $2,180 | $31 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 24 | $1,601 | $52 |
| Radioactive drug therapy through a tube inserted in an artery | 16 | $1,364 | $80 |
| Nuclear medicine study of liver and bile duct system | 44 | $1,266 | $28 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 12 | $893 | $69 |
| Nuclear medicine study of bone taken at different times | 21 | $879 | $37 |
| Nuclear medicine study of stomach to assess emptying | 24 | $872 | $29 |
| Nuclear medicine study of heart muscle at rest and with stress and spect | 16 | $868 | $54 |
| Nuclear medicine study of kidney, blood, flow, and function with drug administration | 14 | $662 | $47 |
| Nuclear medicine study to assess blood loss | 13 | $587 | $39 |
| Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 11 | $507 | $46 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 13 | $497 | $36 |
| Calculation of radiation therapy dose | 16 | $409 | $24 |
| Nuclear medicine study, 1 area | 11 | $361 | $24 |
| Nuclear medicine study, whole body | 11 | $343 | $29 |
| Injection, furosemide, up to 20 mg | 17 | $16 | None |
2021: 19 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 273 | $17,411 | $63 |
| Dxa bone density measurement of hip, pelvis, spine | 777 | $7,886 | $10 |
| Nuclear medicine study of bone and/or joint whole body | 25 | $6,847 | $274 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 243 | $4,379 | $18 |
| Nuclear medicine study of bone and/or joint whole body | 95 | $3,362 | $33 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 255 | $3,065 | $12 |
| Nuclear medicine study of lung circulation | 48 | $1,492 | $30 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 32 | $1,090 | $34 |
| Nuclear medicine study of liver and bile duct system | 37 | $1,074 | $29 |
| Nuclear medicine study of lymphatic system | 20 | $953 | $48 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 14 | $937 | $55 |
| Nuclear medicine study of parathyroid with spect and ct scan | 15 | $822 | $55 |
| Nuclear medicine study of kidney, blood, flow, and function with drug administration | 17 | $821 | $48 |
| Nuclear medicine study of stomach to assess emptying | 22 | $798 | $31 |
| Nuclear medicine study of bone taken at different times | 19 | $780 | $41 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 11 | $510 | $39 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 29 | $350 | $12 |
| Nuclear medicine study, 1 area | 14 | $326 | $23 |
| Nuclear medicine study of thyroid and thyroid function | 11 | $201 | $18 |
2020: 20 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 189 | $12,776 | $67 |
| Dxa bone density measurement of hip, pelvis, spine | 656 | $6,776 | $10 |
| Nuclear medicine study of bone and/or joint whole body | 103 | $3,682 | $33 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 190 | $3,588 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 188 | $2,376 | $13 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 19 | $1,632 | $60 |
| Nuclear medicine study of bone taken at different times | 35 | $1,392 | $39 |
| Nuclear medicine study of lung ventilation and circulation | 25 | $1,047 | $42 |
| Nuclear medicine study of liver and bile duct system | 35 | $1,028 | $29 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 25 | $941 | $38 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 15 | $925 | $62 |
| Nuclear medicine study of lymphatic system | 18 | $885 | $49 |
| Nuclear medicine study of parathyroid with spect and ct scan | 13 | $842 | $65 |
| Nuclear medicine study of stomach to assess emptying | 20 | $751 | $30 |
| Nuclear medicine study of kidney, blood, flow, and function with drug administration | 14 | $743 | $50 |
| Nuclear medicine study of lung circulation | 22 | $644 | $29 |
| Nuclear medicine study to assess blood loss | 14 | $533 | $38 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 12 | $526 | $40 |
| Calculation of radiation therapy dose | 16 | $498 | $28 |
| Nuclear medicine study, 1 area | 14 | $375 | $25 |
2019: 17 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 283 | $17,399 | $61 |
| Dxa bone density measurement of hip, pelvis, spine | 591 | $5,932 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 278 | $5,097 | $18 |
| Nuclear medicine study of lung ventilation and circulation | 107 | $4,645 | $43 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 277 | $3,411 | $12 |
| Nuclear medicine study of bone and/or joint whole body | 93 | $3,391 | $33 |
| Nuclear medicine study of stomach to assess emptying | 49 | $1,928 | $31 |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 119 | $1,670 | $14 |
| Nuclear medicine study of bone taken at different times | 30 | $1,551 | $41 |
| Nuclear medicine study of liver and bile duct system | 49 | $1,463 | $30 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 19 | $935 | $43 |
| Nuclear medicine study to assess blood loss | 16 | $649 | $38 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 11 | $630 | $35 |
| Nuclear medicine study of kidney, blood, flow, and function with drug administration | 12 | $579 | $48 |
| Dxa bone density measurement of forearm, finger, hand, or foot | 53 | $553 | $10 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 11 | $364 | $33 |
| Nuclear medicine study of thyroid and thyroid function | 19 | $341 | $18 |
2018: 16 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 207 | $20,454 | $96 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 301 | $17,254 | $57 |
| Nuclear medicine study of lung ventilation and circulation | 96 | $3,960 | $40 |
| Nuclear medicine study of bone and/or joint whole body | 98 | $3,222 | $31 |
| Nuclear medicine study whole body with ct scan | 22 | $2,257 | $98 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 105 | $1,848 | $17 |
| Nuclear medicine study of bone taken at different times | 26 | $1,409 | $38 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 40 | $1,333 | $33 |
| Nuclear medicine study of stomach to assess emptying | 38 | $1,324 | $30 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 103 | $1,214 | $12 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 22 | $891 | $41 |
| Nuclear medicine study of liver and bile duct system | 31 | $885 | $28 |
| Nuclear medicine study to assess blood loss | 17 | $613 | $34 |
| Nuclear medicine study of radioactive material distribution at site of inflammation | 13 | $561 | $28 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 11 | $453 | $35 |
| Nuclear medicine study of bone and/or joint | 11 | $335 | $30 |
2017: 18 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 350 | $39,783 | $97 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 321 | $19,726 | $61 |
| Nuclear medicine study of lung ventilation and circulation | 113 | $4,828 | $42 |
| Nuclear medicine study whole body with ct scan | 31 | $3,762 | $99 |
| Nuclear medicine study of bone and/or joint whole body | 57 | $2,022 | $34 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 106 | $1,908 | $18 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 51 | $1,789 | $34 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 96 | $1,154 | $12 |
| Nuclear medicine study of bone taken at different times | 25 | $1,112 | $38 |
| Nuclear medicine study of stomach to assess emptying | 21 | $799 | $32 |
| Nuclear medicine study of parathyroid with spect | 17 | $732 | $43 |
| Nuclear medicine study of heart muscle at rest and with stress and spect | 15 | $716 | $48 |
| Nuclear medicine study of bone and/or joint | 20 | $705 | $35 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 13 | $681 | $43 |
| Nuclear medicine study of lymphatic system | 11 | $531 | $48 |
| Nuclear medicine study to assess blood loss | 11 | $480 | $40 |
| Nuclear medicine study of liver and bile duct system | 15 | $449 | $28 |
| Nuclear medicine study of radioactive material distribution at site of inflammation | 15 | $440 | $27 |
2016: 22 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 359 | $42,088 | $96 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 257 | $16,770 | $64 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 103 | $11,576 | $98 |
| Nuclear medicine study of lung ventilation and circulation | 95 | $4,191 | $43 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 224 | $4,115 | $18 |
| Nuclear medicine study whole body with ct scan | 37 | $3,759 | $99 |
| Nuclear medicine study of bone taken at different times | 48 | $2,683 | $41 |
| Nuclear medicine study of bone and/or joint whole body | 67 | $2,397 | $34 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 197 | $2,362 | $12 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 55 | $2,012 | $37 |
| Nuclear medicine study whole body with ct scan | 16 | $1,780 | $99 |
| Nuclear medicine study of parathyroid with spect | 24 | $1,156 | $48 |
| Nuclear medicine study of radioactive material distribution at site of inflammation | 26 | $940 | $29 |
| Nuclear medicine study of kidney, blood, flow, and function with drug administration | 18 | $872 | $48 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 12 | $768 | $43 |
| Nuclear medicine study of heart muscle at rest and with stress and spect | 12 | $717 | $55 |
| Nuclear medicine study of stomach to assess emptying | 22 | $697 | $29 |
| Nuclear medicine study of bone and/or joint | 15 | $660 | $41 |
| Nuclear medicine study to assess blood loss | 12 | $561 | $40 |
| Nuclear medicine study of radioactive material distribution at sites of inflammation in whole body | 16 | $550 | $34 |
| Nuclear medicine study of liver and bile duct system | 13 | $390 | $30 |
| Nuclear medicine study of lung circulation | 12 | $360 | $30 |
2015: 19 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 263 | $179,434 | $655 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 147 | $28,405 | $191 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 91 | $8,755 | $94 |
| Nuclear medicine study whole body with ct scan | 15 | $7,947 | $530 |
| Nuclear medicine study of bone and/or joint whole body | 32 | $6,660 | $208 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 109 | $6,341 | $58 |
| Nuclear medicine study of lung ventilation and circulation | 79 | $3,216 | $41 |
| Nuclear medicine study of bone and/or joint | 19 | $1,756 | $92 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 116 | $1,319 | $11 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 98 | $1,232 | $0 |
| Nuclear medicine study of bone and/or joint whole body | 34 | $1,074 | $32 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 28 | $930 | $33 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 54 | $902 | $17 |
| Nuclear medicine study to assess blood loss | 12 | $713 | $40 |
| Dxa bone density measurement of hip, pelvis, spine | 60 | $619 | $10 |
| Nuclear medicine study of liver and bile duct system | 21 | $563 | $27 |
| Nuclear medicine study of bone taken at different times | 17 | $539 | $32 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 35 | $508 | $15 |
| Nuclear medicine study of stomach to assess emptying | 13 | $328 | $23 |
2014: 26 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 210 | $287,083 | $1,186 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 212 | $48,109 | $196 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 321 | $20,209 | $62 |
| Nuclear medicine study of bone and/or joint whole body | 73 | $15,340 | $210 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 83 | $8,740 | $98 |
| Nuclear medicine study of lung ventilation and circulation | 195 | $8,131 | $41 |
| Nuclear medicine study of bone taken at different times | 16 | $4,737 | $296 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 319 | $3,739 | $12 |
| Nuclear medicine study of bone and/or joint | 33 | $3,214 | $97 |
| Nuclear medicine study of bone and/or joint whole body | 102 | $3,138 | $31 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 67 | $2,480 | $36 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 139 | $2,397 | $17 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 114 | $1,809 | $0 |
| Nuclear medicine study to assess blood loss | 43 | $1,788 | $40 |
| Nuclear medicine study of stomach to assess emptying | 48 | $1,596 | $31 |
| Nuclear medicine study of bone taken at different times | 39 | $1,595 | $41 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 88 | $1,456 | $14 |
| Dxa bone density measurement of hip, pelvis, spine | 115 | $1,203 | $10 |
| Nuclear medicine study of radioactive material distribution at sites of inflammation in whole body | 30 | $1,020 | $34 |
| Nuclear medicine study of liver and bile duct system | 30 | $898 | $30 |
| Nuclear medicine study of heart muscle at rest and with stress and spect | 15 | $879 | $55 |
| Nuclear medicine study of bone and/or joint | 21 | $817 | $37 |
| Nuclear medicine study of kidney, blood, flow, and function with drug administration | 14 | $675 | $48 |
| Nuclear medicine study of radioactive material distribution at site of inflammation | 23 | $674 | $29 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 11 | $592 | $42 |
| Nuclear medicine study of thyroid and thyroid function | 13 | $228 | $18 |
2013: 29 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 183 | $201,212 | $982 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 190 | $54,201 | $256 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 447 | $27,020 | $60 |
| Nuclear medicine study of bone and/or joint whole body | 92 | $19,785 | $215 |
| Nuclear medicine study whole body with ct scan | 13 | $13,912 | $994 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 88 | $9,347 | $92 |
| Nuclear medicine study of lung ventilation and circulation | 166 | $7,182 | $42 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 22 | $6,570 | $299 |
| Nuclear medicine study of bone and/or joint | 54 | $5,308 | $98 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 372 | $4,223 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 209 | $3,545 | $17 |
| Nuclear medicine study of bone taken at different times | 12 | $2,922 | $243 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 78 | $2,794 | $34 |
| Nuclear medicine study of bone and/or joint whole body | 88 | $2,613 | $29 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 102 | $1,952 | $15 |
| Nuclear medicine study of bone taken at different times | 46 | $1,748 | $37 |
| Nuclear medicine study of heart muscle at rest and with stress and spect | 25 | $1,271 | $51 |
| Nuclear medicine study of stomach to assess emptying | 44 | $1,254 | $28 |
| Injection, sincalide, 5 micrograms | 22 | $1,174 | None |
| Nuclear medicine study to assess blood loss | 29 | $1,094 | $38 |
| Nuclear medicine study of radioactive material distribution at sites of inflammation in whole body | 32 | $969 | $30 |
| Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 22 | $897 | $41 |
| Nuclear medicine study of liver and bile duct system | 25 | $742 | $30 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 15 | $641 | $40 |
| Nuclear medicine study of parathyroid with spect | 12 | $548 | $46 |
| Nuclear medicine study of radioactive material distribution at site of inflammation | 18 | $502 | $28 |
| Nuclear medicine study of bone and/or joint | 11 | $428 | $36 |
| Dxa bone density measurement of hip, pelvis, spine | 32 | $310 | $10 |
| Nuclear medicine study of thyroid and thyroid function | 17 | $268 | $16 |
Medicaid work
$27,461 in 2024
Medicaid paid $27,461 for 1,121 billed services this clinician did in 2024, up to 34 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| BONE IMAGING WHOLE BODY | 185 | $12,273 |
| Gastric emptying imaging study (eg, solid, liquid, or both) | 44 | $10,134 |
| THYROID IMAGING W/BLOOD FLOW | 13 | $2,129 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 252 | $1,359 |
| CARDIOVASCULAR STRESS TEST | 251 | $863 |
| CARDIOVASCULAR STRESS TEST | 245 | $586 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 40 | $101 |
| DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL | 91 | $16 |
| 2024 | 1,121 | 8 | 34 | $27,461 |
| 2023 | 1,624 | 8 | 52 | $17,178 |
| 2022 | 743 | 6 | 32 | $2,081 |
| 2021 | 82 | 3 | 15 | $651 |
| 2020 | 17 | 1 | 17 | $47 |
| 2019 | 187 | 3 | 22 | $1,142 |
| 2018 | 288 | 3 | 25 | $2,411 |
See the largest Medicaid services in earlier years
2023
| Gastric emptying imaging study (eg, solid, liquid, or both) | 37 | $7,453 |
| BONE IMAGING WHOLE BODY | 158 | $6,058 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 402 | $1,425 |
| CARDIOVASCULAR STRESS TEST | 374 | $988 |
| CARDIOVASCULAR STRESS TEST | 422 | $690 |
| HEPATOBILIARY SYST IMAGING INCLUDING GALLBLADDER | 89 | $282 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 102 | $241 |
| DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL | 40 | $40 |
2022
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 245 | $940 |
| BONE IMAGING WHOLE BODY | 26 | $535 |
| CARDIOVASCULAR STRESS TEST | 176 | $247 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 68 | $158 |
| CARDIOVASCULAR STRESS TEST | 213 | $149 |
| HEPATOBILIARY SYST IMAGING INCLUDING GALLBLADDER | 15 | $53 |
2021
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 56 | $339 |
| BONE IMAGING WHOLE BODY | 12 | $281 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 14 | $31 |
2020
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 17 | $47 |
2019
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 121 | $941 |
| CARDIOVASCULAR STRESS TEST | 41 | $105 |
| CARDIOVASCULAR STRESS TEST | 25 | $96 |
2018
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 219 | $1,449 |
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 57 | $925 |
| CARDIOVASCULAR STRESS TEST | 12 | $37 |
Money from drug and device companies
$211 in 2019
A payment is not proof that care is biased.
| Pfizer | Vyndaqel | $123 | 1 payment
|
| Cook Medical | Cook Medical Zilver Ptx | $88 | 2 payments
|
See all 3 published payments
| Pfizer | Meals · 2019-09-19 | Vyndaqel | $123 |
| Cook Medical | Meals · 2019-03-07 | Cook Medical Zilver Ptx | $75 |
| Cook Medical | Meals · 2019-03-05 | Cook Medical Zilver Ptx | $13 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 95.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1780635508
- Licence
- CA A66845California A66845: Current · expires 2028-08-31
- Trained
- Medical College of Wisconsin, 1997 · 29 years ago
- Group
- Saint Agnes Medical Foundation · Beverly Radiology Medical Group III · Kern Radiology Medical Group Inc · Fresno Imaging Center · Desert Advanced Imaging Medical Center
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A668450
- Taxonomy
- Federal specialty code 207U00000X (207U00000X); Federal specialty code 207UN0903X (207UN0903X)
- Mailing address
- Po Box 6102, Novato, CA, 94948
- NPI first listed
- 2006-05-15
- NPI last updated
- 2018-01-12
This is when the NPI record was last certified, not a medical board exam.